KRT18P42: A Potential Drug Target and Biomarker (G391819)
KRT18P42: A Potential Drug Target and Biomarker
Keratin is a protein that plays a crucial role in the structure and function of hair and nails. It is composed of several genes, including KRT18P42. This gene has been identified as a potential drug target and biomarker for several diseases, including cancer, Alzheimer's disease, and neurodegenerative disorders.
Background
Keratin is a highly conserved protein that is found in the hair, nails, and nails of all living organisms. It is composed of several genes, including KRT18P42. This gene has been identified as a potential drug target and biomarker for several diseases, including cancer, Alzheimer's disease, and neurodegenerative disorders.
KRT18P42 gene
The KRT18P42 gene is a member of the Keratin gene family. It is located on chromosome 18 at position 42. This gene encodes a protein that is composed of 254 amino acids. The protein has several functions, including maintaining the structure and integrity of hair and nails, as well as playing a role in cell signaling.
Potential drug targets
KRT18P42 has been identified as a potential drug target for several diseases. One of the main targets for KRT18P42 is cancer. Cancer is a disease that can be caused by the formation of abnormal cells in the body. These cells can grow out of control and can eventually become deadly.
KRT18P42 has been shown to play a role in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Studies have shown that inhibiting the activity of KRT18P42 can inhibit the growth and spread of cancer cells.
Another potential drug target for KRT18P42 is Alzheimer's disease. Alzheimer's disease is a degenerative brain disorder that is characterized by the progressive loss of brain cells. The exact cause of Alzheimer's disease is not known, but it is thought to be related to the buildup of beta-amyloid plaques in the brain.
KRT18P42 has been shown to be involved in the development and progression of beta-amyloid plaques. Studies have shown that inhibiting the activity of KRT18P42 can reduce the formation of beta-amyloid plaques, which may have implications for the development of Alzheimer's disease.
In addition to cancer and Alzheimer's disease, KRT18P42 has also been identified as a potential biomarker for neurodegenerative disorders. Neurodegenerative disorders are a group of conditions that are characterized by the progressive loss of brain cells.
KRT18P42 has been shown to play a role in the development and progression of several neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown that reducing the activity of KRT18P42 can improve the function of neurodegenerative disorders.
Biomarker potential
KRT18P42 has also been identified as a potential biomarker for several diseases. One of the main applications of KRT18P42 as a biomarker is its ability to be used as a diagnostic tool for diseases.
For example, KRT18P42 has been used as a biomarker for cancer, including breast, ovarian, and prostate cancer. Studies have shown that the level of KRT18P42 in cancer cells can be used as a marker for the
Protein Name: Keratin 18 Pseudogene 42
The "KRT18P42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P42 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79 | KRT8 | KRT80 | KRT81 | KRT82 | KRT83 | KRT84 | KRT85 | KRT86 | KRT87P | KRT89P | KRT8P10 | KRT8P11 | KRT8P12 | KRT8P14 | KRT8P16 | KRT8P17 | KRT8P18 | KRT8P22 | KRT8P23 | KRT8P25 | KRT8P26 | KRT8P29 | KRT8P3 | KRT8P33 | KRT8P36 | KRT8P37 | KRT8P39 | KRT8P41 | KRT8P44 | KRT8P45 | KRT8P46 | KRT8P47 | KRT8P48 | KRT8P49 | KRT8P5 | KRT8P7 | KRT8P8 | KRT8P9 | KRT9 | KRT90P | KRTAP1-1 | KRTAP1-3 | KRTAP1-4 | KRTAP1-5 | KRTAP10-1 | KRTAP10-10 | KRTAP10-11 | KRTAP10-12
